Raffles Medical Group Ltd Financials

Market Capitalization S$1.87 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	33.67
Forward PE	25.25
Price to Sales TTM	S$2.48
Price to Book MRQ	S$1.79
Enterprise to Revenue	2.14
Enterprise to EBITDA	13.97

Financial Reports as of Dec. 31, 2019

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2019-12-31
Profit Margin	8.27%
Operating Margin	11.33%
Return on Assets TTM	3.48%
Return on Equity TTM	5.91%

Income Statement

Revenue TTM	S$752,411,008
Revenue per Share TTM	S$0.41
Quarterly Revenue Growth	14.70%
Gross Profit TTM	S$339,017,984
EBITDA	S$109,210,000
Net Income to Common TTM	S$62,243,000
Diluted EPS TTM	S$0.03
Quarterly Earnings Growth YoY	4.30%

Balance Sheet

Total Cash MRQ	S$343,671,008
Total Cash per Share MRQ	S$0.19
Total Debt MRQ	S$
Total Debt to Equity MRQ	8.67
Current Ratio MRQ	1.35
Book Value per Share MRQ	S$0.57

Cash Flow

Operating Cash Flow TTM	S$86,254,000
Levered Free Cash Flow TTM	S$57,598,124

BSL Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	1,850,899,968
Float Shares	787,128,462
Avg 10 Volume	2,178,810
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	57.67%
% Held by Institutions	13.54%

Stock Price Summary

Beta	0.32
Fifty Two Week Low	S$0.82
Fifty Two Week High	S$1.05
Fifty Two Week Change	0.00%
Day 50 MA	S$0.99
Day 200 MA	S$0.92

Dividends and Splits

Forward Annual Dividend Rate	S$0.10
Forward Annual Dividend Yield	9.90%
Trailing Annual Dividend Rate	S$0.03
Trailing Annual Dividend Yield	2.48%
Payout Ratio	71.86%
Dividend Date
Ex Dividend Date	2025-05-13
Last Split Factor
Last Split Date	2016-05-09